Summit Therapeutics PLC（SMMT）今日盘前股价大涨近12%，引发市场关注。
公司财报显示，SMMT最新一季（2024财年第四季度）每股调整后亏损0.07美元，好于分析师一致预期的0.08美元亏损。公司业绩表现优于预期，可能是推动其股价大涨的主因。
投资者对公司业绩向好的前景表示欢迎，体现在股价的大涨之中。不过，盘前数据往往也会随着盘中行情而发生变化，SMMT股价能否继续保持强劲表现还有待进一步观察。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.